Louisa L. Lo

A Phase Ib Dose-Escalation and Expansion Study of the BCL2 Inhibitor Venetoclax Combined with Tamoxifen in ER and BCL2–Positive Metastatic Breast Cancer

Sheau Wen Lok, James R. Whittle, François Vaillant et al. · Cancer Discovery · 2019 · 145 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16

Alpelisib Monotherapy for PI3K-Altered, Pretreated Advanced Breast Cancer: A Phase II Study

Peter Savas, Louisa L. Lo, Stephen J. Luen et al. · Cancer Discovery · 2022 · 55 citations · Full text

Medicine, Oncology, Pharmacology +14

Circulating tumour DNA in metastatic breast cancer to guide clinical trial enrolment and precision oncology: A cohort study

Andjelija Zivanovic Bujak, Chen-Fang Weng, Maria João Silva et al. · PLoS Medicine · 2020 · 34 citations · Full text

Medicine, Clinical Sciences, Oncology +17

Tissue factor expression in the metaplasia–adenoma–carcinoma sequence of gastric cancer in a European population

Louisa L. Lo, Helen Valentine, J. Hartwell Harrison et al. · British Journal of Cancer · 2012 · 22 citations · Full text

Medicine, Oncology, Pathology +16

Validation of the IBIS breast cancer risk evaluator for women with lobular carcinoma in-situ

Louisa L. Lo, Roger L. Milne, Yuyan Liao et al. · British Journal of Cancer · 2018 · 20 citations · Full text

Medicine, Oncology, Breast Oncology +14